Media

Filter by Category

All Blogs Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

January 7, 2014

Coalition Against Major Diseases/European Medicines Agency Biomarker Qualification Of Hippocampal Volume For Enrichment Of Clinical Trials In Predementia Stages Of Alzheimer’s Disease

Dr. Janet Woodcock, Director, Center for Drug Evaluation and Research, on FDA’s Critical Path Initiative

CDISC Data Standard for Multiple Sclerosis Spurs Sharing of Clinical Data

Identifying and Measuring the Core Symptoms Reported by Persons with Asthma: A review of the Existing Qualitative Literature and Patient-Reported Outcome Measures

Development of the Initial Version of the Asthma Daily Symptom Diary

April 29, 2014-April 30, 2014

Fifth Annual Patient-Reported Outcome (PRO) Consortium Workshop

Honoring the Past, Navigating the Present, Charting the Future April 29 – 30, 2014 Sheraton Silver Spring Hotel 8777 Georgia Ave

Nonclinical Safety Biomarkers of Drug-induced Vascular Injury: Current Status and Blueprint for the Future

C-Path’s CEO, Martha A. Brumfield, featured on FasterCures blog

January 4, 2014

Advancing the Portfolio of Tuberculosis Diagnostics, Drugs, Biomarkers, and Vaccines

January 4, 2014

Operationalizing Hippocampal Volume as an Enrichment Biomarker for Amnestic Mild Cognitive Impairment Trials: Effect of Algorithm, Test-Retest Variability, and Cut Point on Trial Cost, Duration, and Sample Size

Previous8687 88...109 Next